PNEUMABORT-K® + 1b is labeled for use in pregnant mares, and to aid in the prevention of abortion due to equine herpesvirus Type 1 (EHV-1) infections, and to aid in the prevention of respiratory disease caused by EHV-1p and EHV-1b in healthy horses 9 months of age and older.
In the fifth, seventh and ninth months of gestation, mares need a vaccine labeled to help protect against abortion caused by EHV-1. In fact, pregnant mares have more than four times greater risk of abortion due to EHV-1 when not vaccinated.1-4
For use with Equine
Available as Killed virus vaccine
Indications
PNEUMABORT K® +1b has been shown to be effective in healthy horses 9 months of age or older to help protect against respiratory disease cased by EHV-1p and EHV-1b and for use in pregnant mares to aid in prevention of abortion due to EHV-1 infections.
HOW IT WORKS
PNEUMABORT K® +1b has been shown to be effective in healthy horses 9 months of age or older to help protect against respiratory disease caused by EHV-1p and EHV-1b and for use in pregnant mares to aid in prevention of abortion due to EHV-1 infections.
What Is It For?
For the vaccination of healthy horses 9 months of age or older against EHV-1.
- Recommended for whole-herd management — including geldings, stallions and mares — where there is evidence of EHV-1 in the herd population.
- In the fifth, seventh and ninth months of gestation, mares need a vaccine labeled to help protect against abortion caused by EHV-1. In fact, pregnant mares have more than four times greater risk of abortion due to EHV-1 when not vaccinated.1-4
Dosage and Administration
- For pregnant mares, aseptically administer one 2-mL dose intramuscularly (IM) during the fifth, seventh and ninth months of each pregnancy.
- To aid in the prevention of EHV-1 respiratory disease in young horses, aseptically administer one 2-mL dose IM after weaning, followed by a second 2-mL dose three to four weeks later. Revaccinate with a single 2-mL dose six months after the second primary dose and annually thereafter.
- To ensure proper placement and retention of the vaccine, inject deep into the heavy muscles of the hindquarter.
- Mild exercise to promote absorption is recommended for one week after injection.
How Does It Work?
- PNEUMABORT-K® + 1b is adjuvanted for improved immune responses.
- The 1b subgroup of EHV-1 continues to be an important group, as are abortions associated with EHV-1 infections.5
Safety Information
- Shake vigorously to assure uniform suspension of the vaccine.
- An occasional local swelling or induration at the site of injection may be encountered.
- Avoid freezing.
- Store in the dark at 2° C to 7° C (35° F to 45° F).
- When used according to instructions, local or systemic reactions rarely occur.
- Do not vaccinate within 60 days before slaughter.
- Use entire contents when first opened.
- In case of anaphylactoid reaction, administer epinephrine.
Product Support
Zoetis Equine Vaccine Antigen Chart
References
- Bryans JT, Allen GP. Application of a chemically inactivated, adjuvanted vaccine to control abortigenic infection of mares by equine herpesvirus 1. Dev Biol Stand. 1982;52:493-498.
- Tengelsen LA, Yamini B, Mullaney TP, et al. A 12-year retrospective study of equine abortion in Michigan. J Vet Diagn Invest. 1997;9(3):303-306.
- Giles RC, Donahue JM, Hong CB, et al. Causes of abortion, stillbirth, and perinatal death in horses: 3,527 cases (1986-1991). J Am Vet Med Assoc. 1993;203(8):1170-1175.
- Hong CB, Donahue JM, Giles RC, et al. Equine abortion and stillbirth in central Kentucky during 1988 and 1989 foaling seasons. J Vet Diagn Invest. 1993;5(4):560-566.
- Paillot R, Case R, Ross J, Newton R, Nugent J. Equine Herpes Virus-1: Virus, Immunity and Vaccines. The Open Veterinary Science Journal. 2008;2:68-91.
